Bruno Le Grand
8Patents
1h-index
6Co-inventors
40Inventor score
Filing activity: Jun 19, 2007 → Apr 25, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8217046B2 | Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists | Human Necessities | 4 | Active |
| US8513258B2 | Cinnamoyl-piperazine derivatives and their use as par-1 antagonists | Human Necessities | 1 | Active |
| US8022064B2 | Phenylpentadienoyl derivatives and their use as PAR 1 antagonists | Chemistry; Metallurgy | 0 | Active |
| US9433603B2 | Use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine for preventing and/or treating cardiotoxic effects caused by chemotherapy and/or radiation | Human Necessities | 0 | Active |
| US9393228B2 | Combination of a slow sodium current blocker and a sinus If current inhibitor, and the pharmaceutical compositions containing said combination | Human Necessities | 0 | Active |
| US9980970B2 | Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions | Human Necessities | 0 | Active |
| US10265322B2 | Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions | Human Necessities | 0 | Active |
| US9603835B2 | Use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine for treating cancer and in particular for preventing and/or treating cancer metastases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.